E
Eric Renard
Researcher at University of Montpellier
Publications - 307
Citations - 11961
Eric Renard is an academic researcher from University of Montpellier. The author has contributed to research in topics: Diabetes mellitus & Insulin. The author has an hindex of 51, co-authored 269 publications receiving 9598 citations. Previous affiliations of Eric Renard include IMRB International & French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
Tadej Battelino,Thomas Danne,Richard M. Bergenstal,Stephanie A. Amiel,Roy W. Beck,Torben Biester,Emanuele Bosi,Bruce A. Buckingham,William T. Cefalu,Kelly L. Close,Claudio Cobelli,Eyal Dassau,J. Hans DeVries,Kim C. Donaghue,Klemen Dovc,Francis J. Doyle,Satish K. Garg,George Grunberger,Simon Heller,Lutz Heinemann,Irl B. Hirsch,Roman Hovorka,Weiping Jia,Olga Kordonouri,Boris Kovatchev,Aaron J. Kowalski,Lori M. Laffel,Brian J. Levine,Alexander Mayorov,Chantal Mathieu,Helen R. Murphy,Revital Nimri,Kirsten Nørgaard,Christopher G. Parkin,Eric Renard,David Rodbard,Banshi Saboo,Desmond A. Schatz,Keaton C. Stoner,Tatsuiko Urakami,Stuart A. Weinzimer,Moshe Phillip,Moshe Phillip +42 more
TL;DR: This article summarizes the ATTD consensus recommendations for relevant aspects of CGM data utilization and reporting among the various diabetes populations.
Journal ArticleDOI
New-Onset Diabetes in Covid-19.
Francesco Rubino,Stephanie A. Amiel,Paul Zimmet,K. George M.M. Alberti,Stefan R. Bornstein,Robert H. Eckel,Geltrude Mingrone,Bernhard O. Boehm,Mark E. Cooper,Zhonglin Chai,Stefano Del Prato,Linong Ji,David Hopkins,William H. Herman,Kamlesh Khunti,Jean Claude Mbanya,Eric Renard +16 more
TL;DR: A large number of patients with or at risk of diabetes and metabolic complications of preexisting diabetes, including diabetic ketoacidosis and h...
Journal ArticleDOI
Artificial Pancreas: Past, Present, Future
TL;DR: The artificial pancreas (AP), known as closed-loop control of blood glucose in diabetes, is a system combining a glucose sensor, a control algorithm, and an insulin infusion device that has proved the feasibility of external glucose control and stimulated further technology development.
Journal ArticleDOI
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial.
Simon Heller,John B. Buse,Miles Fisher,Satish K. Garg,Michel Marre,Ludwig Merker,Eric Renard,David Russell-Jones,David Russell-Jones,Areti Philotheou,Ann Marie Ocampo Francisco,Huiling Pei,Bruce W. Bode +12 more
TL;DR: Insulin degludec might be a useful basal insulin for patients with type 1 diabetes because it provides effective glycaemic control while lowering the risk of nocturnal hypoglycaemia, which is a major limitation of insulin therapy.
Journal ArticleDOI
Fully Integrated Artificial Pancreas in Type 1 Diabetes: Modular Closed-Loop Glucose Control Maintains Near Normoglycemia
Marc D. Breton,Anne Farret,Daniela Bruttomesso,Stacey M. Anderson,Lalo Magni,Stephen D. Patek,Chiara Dalla Man,Jerome Place,Susan Demartini,Simone Del Favero,Chiara Toffanin,Colleen Hughes-Karvetski,Eyal Dassau,Howard Zisser,Francis J. Doyle,Giuseppe De Nicolao,Angelo Avogaro,Claudio Cobelli,Eric Renard,Boris Kovatchev +19 more
TL;DR: In this article, the authors presented a modular concept for integrated closed-loop control (CLC) design, illustrated by clinical studies involving 11 adolescents and 27 adults at the Universities of Virginia, Padova, and Montpellier.